Latest News

Debiopharm co-leads an investment round of €10 million in Oncomfort

Belgian scale-up Oncomfort raises €10 million in Series A funding co-led by Debiopharm and Crédit Mutuel Innovation to further develop…

Nucleai Secured $6.5m Series-A Initial Closing Led by Debiopharm to Advance Ai-Powered Precision Oncology Platform

Debiopharm invests in NucleAI– using AI to develop digital pathology biomarkers

Immunexpress awarded funding to develop their COVID-19 patient triage test SeptiCyte® RAPID

Acquisition of Kaiku Health by the swedish company Elekta

Acquisition of Debiopharm’s Investment Portfolio Company Kaiku Health Broadens Patient Access to Digital Oncology Intervention

BC Platforms Honored by Microsoft for their Efforts to “Reimagine Health” with Kaiser Permanente

Kaiku Health and the Geneva University Hospitals implement digital symptom monitoring for COVID-19 patients in Switzerland